Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Bacterial Conjunctivitis

In brief

The purpose of this clinical trial is to demonstrate the superiority of fusidic acid 1% over placebo in adults and children with confirmed bacterial conjunctivitis and to further establish the safety profile of fusidic acid 1% for topical ocular administration.

Key facts

Study ID
NCT06911424
Run by
Baxis Pharmaceuticals, Inc.
People needed
400
Starts
2025-03-21
Expected to finish
2026-03-23
Last updated by the study team
2026-03-17

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.